Combining CTLA-4 Agents With PD-1/PD-L1 Agents in Lung Cancer

August 18, 2017
David R. Gandara, MD

David R. Gandara, MD, director, Thoracic Oncology Program, and professor, UC Davis Comprehensive Cancer Center, discusses the combination of CTLA-4 agents with PD-1 and PD-L1 agents for the treatment of lung cancer.